SECUKINUMAB IMPROVES SIGNS AND SYMPTOMS OF PSORIATIC ARTHRITIS: RESULTS FROM A PHASE 3 STUDY, FUTURE 5

被引：0
|
作者：
Mease, Philip J. [1 ,2 ]
van der Heijde, D. [3 ]
Landewe, R. [4 ,5 ]
Mpofu, S. [6 ]
Rahman, P. [7 ]
Tahir, H. [8 ]
Singhal, A. [9 ]
Navarra, S. [10 ]
Boettcher, E. [10 ]
Zhu, X. [11 ]
Readie, A. [11 ]
Pricop, L. [11 ]
Abrams, K. [11 ]
机构：
[1] Swedish Med Ctr, Seattle, WA USA
[2] Univ Washington, Seattle, WA 98195 USA
[3] Leiden Univ, Med Ctr, Leiden, Netherlands
[4] Univ Amsterdam, Amsterdam, Netherlands
[5] Atrium Med Ctr, Amsterdam, Netherlands
[6] Novartis, Pharma AG, Basel, Switzerland
[7] Mem Univ Newfoundland, St John, NF, Canada
[8] Cross Hosp, Whipps, London, England
[9] Southwest Rheumatol, Dallas, TX USA
[10] Rheumazentrum Favoriten, Vienna, Austria
[11] Nova Pharmaceut Corp, E Hanover, NJ USA
来源：
ACTA DERMATO-VENEREOLOGICA | 2018年 / 98卷
关键词：
D O I：
暂无
中图分类号：
R75 [皮肤病学与性病学];
学科分类号：
100206 ;
摘要：
P036
引用
收藏
页码：17 / 18
页数：2
相关论文
共 50 条
  • [1] Secukinumab improves signs and symptoms of psoriatic arthritis: Results of phase 3 FUTURE 2 study stratified by concomitant methotrexate use
    Gottlieb, Alice B.
    McInnes, Iain
    Mease, Philip
    Mpofu, Shephard
    [J]. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2016, 74 (05) : AB270 - AB270
  • [2] Secukinumab sustains improvement in signs and symptoms of psoriatic arthritis: 2 year results from the phase 3 FUTURE 2 study
    McInnes, Iain B.
    Mease, Philip J.
    Ritchlin, Christopher T.
    Rahman, Proton
    Gottlieb, Alice B.
    Kirkham, Bruce
    Kajekar, Radhika
    Delicha, Eumorphia-Maria
    Pricop, Luminita
    Mpofu, Shephard
    [J]. RHEUMATOLOGY, 2017, 56 (11) : 1993 - 2003
  • [3] Secukinumab Provides Sustained Improvements in the Signs and Symptoms of Psoriatic Arthritis: Final 5-year Results from the Phase 3 FUTURE 1 Study
    Mease, Philip J.
    Kavanaugh, Arthur
    Reimold, Andreas
    Tahir, Hasan
    Rech, Juergen
    Hall, Stephen
    Geusens, Piet
    Pellet, Pascale
    Delicha, Eumorphia Maria
    Pricop, Luminita
    Mpofu, Shephard
    [J]. ACR OPEN RHEUMATOLOGY, 2020, 2 (01) : 18 - 25
  • [4] SECUKINUMAB PROVIDES SUSTAINED IMPROVEMENTS IN THE SIGNS AND SYMPTOMS OF ACTIVE PSORIATIC ARTHRITIS: 3-YEAR RESULTS FROM THE PHASE 3 FUTURE 2 STUDY
    Nash, P.
    McInnes, I. B.
    Rahman, P.
    Gottlieb, A. B.
    Kirkham, B.
    Ding, K.
    Pricop, L.
    [J]. ANNALS OF THE RHEUMATIC DISEASES, 2018, 77 : 379 - 379
  • [5] SECUKINUMAB PROVIDES SUSTAINED IMPROVEMENTS IN THE SIGNS AND SYMPTOMS OF ACTIVE PSORIATIC ARTHRITIS: 4-YEAR RESULTS FROM THE PHASE 3 FUTURE 2 STUDY
    McInnes, Iain B.
    Kirkham, Bruce
    Nash, Peter
    Rahman, Proton
    Gottlieb, Alice B.
    Ding, Kevin
    Pricop, Luminita
    [J]. RHEUMATOLOGY, 2019, 58
  • [6] SECUKINUMAB PROVIDES SUSTAINED IMPROVEMENTS IN THE SIGNS AND SYMPTOMS OF ACTIVE PSORIATIC ARTHRITIS: 104 WEEKS RESULTS FROM A PHASE 3 TRIAL, FUTURE 2
    McInnes, I. B.
    Mease, P. J.
    Ritchlin, C.
    Rahman, P.
    Gottlieb, A.
    Kirkham, B.
    Kajekar, R.
    Delicha, E. M.
    Pricop, L.
    Mpofu, S.
    [J]. ANNALS OF THE RHEUMATIC DISEASES, 2017, 76 : 145 - 145
  • [7] Secukinumab improves symptoms of psoriatic arthritis
    João H. Duarte
    [J]. Nature Reviews Rheumatology, 2015, 11 (9) : 503 - 503
  • [8] SECUKINUMAB PROVIDES SUSTAINED IMPROVEMENTS IN THE SIGNS AND SYMPTOMS IN PSORIATIC ARTHRITIS: FINAL 5-YEAR EFFICACY AND SAFETY RESULTS FROM THE FUTURE 1 PHASE 3 TRIAL
    Tahir, Hasan
    Mease, Philip J.
    Kavanaugh, Arthur
    Reimold, Andreas
    Rech, Juergen
    Hall, Stephen
    Geusens, Piet
    Pellet, Pascale
    Delicha, Eumorphia Maria
    Pricop, Luminita
    Mpofu, Shephard
    [J]. RHEUMATOLOGY, 2019, 58 : 151 - 151
  • [9] Secukinumab Provides Sustained Improvements in the Signs and Symptoms in Psoriatic Arthritis: Final 5 Year Efficacy and Safety Results from a Phase 3 Trial
    Mease, Philip J.
    Kavanaugh, Arthur
    Reimold, Andreas
    Tahir, Hasan
    Rech, Juergen
    Hall, Stephen
    Geusens, Piet
    Pascale, Pellet
    Delicha, Evie Maria
    Pricop, Luminita
    Mpofu, Shephard
    [J]. ARTHRITIS & RHEUMATOLOGY, 2018, 70
  • [10] SECUKINUMAB PROVIDES SUSTAINED IMPROVEMENTS IN THE SIGNS AND SYMPTOMS IN PSORIATIC ARTHRITIS: FINAL 5 YEAR EFFICACY AND SAFETY RESULTS FROM A PHASE 3 TRIAL
    Mease, Philip J.
    Kavanaugh, Arthur
    Reimold, Andreas
    Tahir, Hasan
    Rech, Juergen
    Hall, Stephen
    Geusens, Piet
    Pellet, Pascale
    Delicha, Eumorphia Maria
    Pricop, Luminita
    Mpofu, Shephard
    [J]. ANNALS OF THE RHEUMATIC DISEASES, 2019, 78 : 917 - 917
12345